Identification of Novel AR-Targeted MicroRNAs Mediating Androgen Signalling through Critical Pathways to Regulate Cell Viability in Prostate Cancer

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Mo, Wenjuan ^a   Zhang, Jiyuan ^a   Li, Xia ^a   Meng, Delong ^a   Gao, Yun ^a   Yang, Shu ^a   Wan, Xuechao ^a   Zhou, Caihong ^a   Guo, Fenghua ^a   Huang, Yan ^a   Amente, Stefano ^b   Avvedimento, Enrico V ^b   Xie, Yi ^a   Li, Yao ^a  

^a FUDAN UNIVERSITY   (China)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; ANDROGEN RECEPTOR; ANDROSTANOLONE; MEMBRANE PROTEIN; MICRORNA; MICRORNA 133B; MICRORNA 19A; MICRORNA 27A; PROTEIN CDC2L5; PROTEIN CPNE3; PROTEIN PDS5B; PROTEIN PSAP; PROTEIN PTPRK; PROTEIN RAB13; PROTEIN RB1CC1; PROTEIN SC4MOL; PROTEIN SUZ12; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CELL STIMULATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE TARGETING; HUMAN; HUMAN CELL; MALE; MICROARRAY ANALYSIS; PROSTATE CANCER; PROTEIN FUNCTION; RNA ANALYSIS; SIGNAL TRANSDUCTION; UPREGULATION; VALIDATION PROCESS;

ALGORITHMS; ANDROGENS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CHROMATIN IMMUNOPRECIPITATION; CRITICAL PATHWAYS; HUMANS; MALE; MICRORNAS; MODELS, THEORETICAL; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 84874309132     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056592     Document Type: Article

References (47)

1. Liu C, Tang DG, (2011) MicroRNA regulation of cancer stem cells. Cancer Res 71: 5950-5954.
2. Mihelich BL, Khramtsova EA, Arva N, Vaishnav A, Johnson DN, et al. (2011) miR-183-96-182 cluster is overexpressed in prostate tissue and regulates zinc homeostasis in prostate cells. J Biol Chem 286: 44503-44511.
3. Martens-Uzunova ES, Jalava SE, Dits NF, van Leenders GJ, Moller S, et al. (2012) Diagnostic and prognostic signatures from the small non-coding RNA transcriptome in prostate cancer. Oncogene 31: 978-991.
4. Takayama K, Tsutsumi S, Katayama S, Okayama T, Horie-Inoue K, et al. (2011) Integration of cap analysis of gene expression and chromatin immunoprecipitation analysis on array reveals genome-wide androgen receptor signaling in prostate cancer cells. Oncogene 30: 619-630.
5. Murata T, Takayama K, Katayama S, Urano T, Horie-Inoue K, et al. (2010) miR-148a is an androgen-responsive microRNA that promotes LNCaP prostate cell growth by repressing its target CAND1 expression. Prostate Cancer Prostatic Dis 13: 356-361.
6. Ribas J, Ni X, Haffner M, Wentzel EA, Salmasi AH, et al. (2009) miR-21: an androgen receptor-regulated microRNA that promotes hormone-dependent and hormone-independent prostate cancer growth. Cancer Res 69: 7165-7169.
7. Shi XB, Xue L, Yang J, Ma AH, Zhao J, et al. (2007) An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells. Proc Natl Acad Sci U S A 104: 19983-19988.
8. Farh KK, Grimson A, Jan C, Lewis BP, Johnston WK, et al. (2005) The widespread impact of mammalian MicroRNAs on mRNA repression and evolution. Science 310: 1817-1821.
9. Jayaswal V, Lutherborrow M, Ma DD, Hwa Yang Y, (2009) Identification of microRNAs with regulatory potential using a matched microRNA-mRNA time-course data. Nucleic Acids Res 37: e60.
10. Lanahan A, Williams JB, Sanders LK, Nathans D, (1992) Growth factor-induced delayed early response genes. Mol Cell Biol 12: 3919-3929.
11. Ambs S, Prueitt RL, Yi M, Hudson RS, Howe TM, et al. (2008) Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer Res 68: 6162-6170.
12. Snedecor GW, Cochran WG (1980) Statistical methods. The Iowa State University Press 7th edition.
13. Louie MC, Yang HQ, Ma AH, Xu W, Zou JX, et al. (2003) Androgen-induced recruitment of RNA polymerase II to a nuclear receptor-p160 coactivator complex. Proc Natl Acad Sci U S A 100: 2226-2230.
14. Anazawa Y, Arakawa H, Nakagawa H, Nakamura Y, (2004) Identification of STAG1 as a key mediator of a p53-dependent apoptotic pathway. Oncogene 23: 7621-7627.
15. Bonci D, Coppola V, Musumeci M, Addario A, Giuffrida R, et al. (2008) The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med 14: 1271-1277.
16. Tong AW, Fulgham P, Jay C, Chen P, Khalil I, et al. (2009) MicroRNA profile analysis of human prostate cancers. Cancer Gene Ther 16: 206-216.
17. Cao R, Wang L, Wang H, Xia L, Erdjument-Bromage H, et al. (2002) Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science 298: 1039-1043.
18. Ozen M, Creighton CJ, Ozdemir M, Ittmann M, (2008) Widespread deregulation of microRNA expression in human prostate cancer. Oncogene 27: 1788-1793.
19. Rokhlin OW, Scheinker VS, Taghiyev AF, Bumcrot D, Glover RA, et al. (2008) MicroRNA-34 mediates AR-dependent p53-induced apoptosis in prostate cancer. Cancer Biol Ther 7: 1288-1296.
20. Jiang M, Ma Y, Chen C, Fu X, Yang S, et al. (2009) Androgen-responsive gene database: integrated knowledge on androgen-responsive genes. Mol Endocrinol 23: 1927-1933.
21. Chiosea S, Jelezcova E, Chandran U, Acquafondata M, McHale T, et al. (2006) Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma. Am J Pathol 169: 1812-1820.
22. Hulsen T, de Vlieg J, Alkema W, (2008) BioVenn- a web application for the comparison and visualization of biological lists using area-proportional Venn diagrams. BMC Genomics 9: 488.
23. Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, et al. (2005) MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21: 2933-2942.
24. Wang X, (2008) miRDB: a microRNA target prediction and functional annotation database with a wiki interface. RNA 14: 1012-1017.
25. Wang X, El Naqa IM, (2008) Prediction of both conserved and nonconserved microRNA targets in animals. Bioinformatics 24: 325-332.
26. Chase A, Cross NC, (2011) Aberrations of EZH2 in cancer. Clin Cancer Res 17: 2613-2618.
27. Crea F, Hurt EM, Mathews LA, Cabarcas SM, Sun L, et al. (2011) Pharmacologic disruption of Polycomb Repressive Complex 2 inhibits tumorigenicity and tumor progression in prostate cancer. Mol Cancer 10: 40.
28. Wang WH, Studach LL, Andrisani OM, (2011) Proteins ZNF198 and SUZ12 are down-regulated in hepatitis B virus (HBV) X protein-mediated hepatocyte transformation and in HBV replication. Hepatology 53: 1137-1147.
29. Bracken AP, Dietrich N, Pasini D, Hansen KH, Helin K, (2006) Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. Genes Dev 20: 1123-1136.
30. Kanda I, Nishimura N, Nakatsuji H, Yamamura R, Nakanishi H, et al. (2008) Involvement of Rab13 and JRAB/MICAL-L2 in epithelial cell scattering. Oncogene 27: 1687-1695.
31. He M, Kratz LE, Michel JJ, Vallejo AN, Ferris L, et al. (2011) Mutations in the human SC4MOL gene encoding a methyl sterol oxidase cause psoriasiform dermatitis, microcephaly, and developmental delay. J Clin Invest 121: 976-984.
32. Fukuchi J, Hiipakka RA, Kokontis JM, Hsu S, Ko AL, et al. (2004) Androgenic suppression of ATP-binding cassette transporter A1 expression in LNCaP human prostate cancer cells. Cancer Res 64: 7682-7685.
33. Yang CM, Lu IH, Chen HY, Hu ML, (2012) Lycopene inhibits the proliferation of androgen-dependent human prostate tumor cells through activation of PPARgamma-LXRalpha-ABCA1 pathway. J Nutr Biochem 23: 8-17.
34. Kang SY, Halvorsen OJ, Gravdal K, Bhattacharya N, Lee JM, et al. (2009) Prosaposin inhibits tumor metastasis via paracrine and endocrine stimulation of stromal p53 and Tsp-1. Proc Natl Acad Sci U S A 106: 12115-12120.
35. Koochekpour S, Lee TJ, Sun Y, Hu S, Grabowski GA, et al. (2008) Prosaposin is an AR-target gene and its neurotrophic domain upregulates AR expression and activity in prostate stromal cells. J Cell Biochem 104: 2272-2285.
36. Culig Z, Hobisch A, Bartsch G, Klocker H, (2000) Androgen receptor-an update of mechanisms of action in prostate cancer. Urol Res 28: 211-219.
37. Maffini MV, Geck P, Powell CE, Sonnenschein C, Soto AM, (2002) Mechanism of androgen action on cell proliferation: AS3 protein as a mediator of proliferative arrest in the rat prostate. Endocrinology 143: 2708-2714.
38. Chen HH, Wong YH, Geneviere AM, Fann MJ, (2007) CDK13/CDC2L5 interacts with L-type cyclins and regulates alternative splicing. Biochem Biophys Res Commun 354: 735-740.
39. Stabel S, Argos P, Philipson L, (1985) The release of growth arrest by microinjection of adenovirus E1A DNA. Embo J 4: 2329-2336.
40. Xu Y, Tan LJ, Grachtchouk V, Voorhees JJ, Fisher GJ, (2005) Receptor-type protein-tyrosine phosphatase-kappa regulates epidermal growth factor receptor function. J Biol Chem 280: 42694-42700.
41. Hamzeh M, Robaire B, (2011) Androgens activate mitogen-activated protein kinase via epidermal growth factor receptor/insulin-like growth factor 1 receptor in the mouse PC-1 cell line. J Endocrinol 209: 55-64.
42. Melkoumian ZK, Peng X, Gan B, Wu X, Guan JL, (2005) Mechanism of cell cycle regulation by FIP200 in human breast cancer cells. Cancer Res 65: 6676-6684.
43. Caudell EG, Caudell JJ, Tang CH, Yu TK, Frederick MJ, et al. (2000) Characterization of human copine III as a phosphoprotein with associated kinase activity. Biochemistry 39: 13034-13043.
44. Abbi S, Ueda H, Zheng C, Cooper LA, Zhao J, et al. (2002) Regulation of focal adhesion kinase by a novel protein inhibitor FIP200. Mol Biol Cell 13: 3178-3191.
45. Fletcher CE, Dart DA, Sita-Lumsden A, Cheng H, Rennie PS, et al. (2012) Androgen-regulated processing of the oncomir MiR-27a, which targets Prohibitin in prostate cancer. Hum Mol Genet 21: 3112-3127.
46. Patron JP, Fendler A, Bild M, Jung U, Muller H, et al. (2012) MiR-133b targets antiapoptotic genes and enhances death receptor-induced apoptosis. PLoS One 7: e35345.
47. Monteys AM, Spengler RM, Wan J, Tecedor L, Lennox KA, et al. (2010) Structure and activity of putative intronic miRNA promoters. Rna 16: 495-505.